uniQure N.V. Salary and Wage, Excluding Cost of Good and Service Sold
uniQure N.V. (QURE) reported Salary and Wage, Excluding Cost of Good and Service Sold of $71.85 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalariesWagesAndOfficersCompensation · last filed 2024-02-28
- uniQure N.V. salary and wage, excluding cost of good and service sold for fiscal 2023 was $71.85M, a 12.79% increase from fiscal 2022.
- uniQure N.V. salary and wage, excluding cost of good and service sold for fiscal 2022 was $63.70M, a 20.02% increase from fiscal 2021.
- uniQure N.V. salary and wage, excluding cost of good and service sold for fiscal 2021 was $53.08M, a 29.71% increase from fiscal 2020.
- uniQure N.V. salary and wage, excluding cost of good and service sold for fiscal 2020 was $40.92M, a 27.76% increase from fiscal 2019.
| Period end | Salary and Wage, Excluding Cost of Good and Service Sold 12 month |
|---|---|
| 2023-12-31 | $71.85M 10-K · filed 2024-02-28 |
| 2022-12-31 | $63.70M 10-K · filed 2024-02-28 |
| 2021-12-31 | $53.08M 10-K · filed 2024-02-28 |
| 2020-12-31 | $40.92M 10-K · filed 2023-02-27 |
| 2019-12-31 | $32.03M 10-K · filed 2022-02-25 |
| 2018-12-31 | $26.65M 10-K · filed 2021-03-01 |
| 2017-12-31 | $25.13M 10-K · filed 2020-03-02 |
| 2016-12-31 | $25.00M 10-K · filed 2019-02-28 |
| 2015-12-31 | $19.27M 10-K · filed 2018-03-14 |
| 2014-12-31 | $15.64M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |